These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Koledova VV; Khalil RA Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655 [TBL] [Abstract][Full Text] [Related]
3. [Effects of estrogens and progestogens on the lipid profile in postmenopausal hypogonadism]. García L; Hernández I; Cervera Aguilar R; Ayala AR Ginecol Obstet Mex; 2001 Sep; 69():351-4. PubMed ID: 11816532 [TBL] [Abstract][Full Text] [Related]
4. Estrogens, homocysteine, vasodilatation and menopause: basic mechanisms, interactions and clinical implications. Smolders RG; van der Mooren MJ; Sipkema P; Kenemans P Gynecol Endocrinol; 2003 Aug; 17(4):339-54. PubMed ID: 14503980 [TBL] [Abstract][Full Text] [Related]
5. Correlation of atherogenetic biomarkers and estradiol changes in postmenopause. Ratiani L; Parkosadze G; Koptonashvili L; Ormotsadze G; Sulaqvelidze M; Sanikidze T Georgian Med News; 2011 Jun; (195):100-5. PubMed ID: 21778553 [TBL] [Abstract][Full Text] [Related]
6. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women. Bingol B; Gunenc Z; Yilmaz M; Biri A; Tiras B; Güner H Arch Gynecol Obstet; 2010 May; 281(5):857-64. PubMed ID: 19593578 [TBL] [Abstract][Full Text] [Related]
7. [Hormone replacement therapy and cardiovascular risk in postmenopausal women]. Kovacev-Zavisić B; Icin T; Kovacev N Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123 [TBL] [Abstract][Full Text] [Related]
8. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones]. Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240 [TBL] [Abstract][Full Text] [Related]
9. [Effect of hormone replacement therapy on the cardiovascular system]. Payer J Cas Lek Cesk; 2001 Feb; 140(3):67-9. PubMed ID: 11284420 [TBL] [Abstract][Full Text] [Related]
10. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women. Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733 [TBL] [Abstract][Full Text] [Related]
11. Plasma orexin-A levels in postmenopausal women: possible interaction with estrogen and correlation with cardiovascular risk status. El-Sedeek MSh; Korish AA; Deef MM BJOG; 2010 Mar; 117(4):488-92. PubMed ID: 20105164 [TBL] [Abstract][Full Text] [Related]
12. [Hormone replacement therapy and cardiovascular risk]. Maffei S; De Caterina R G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173 [TBL] [Abstract][Full Text] [Related]
13. A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials. Stevenson JC; Chines A; Pan K; Ryan KA; Mirkin S J Clin Endocrinol Metab; 2015 Jun; 100(6):2329-38. PubMed ID: 25894963 [TBL] [Abstract][Full Text] [Related]
14. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women]. da Silva PM Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165 [TBL] [Abstract][Full Text] [Related]
15. Effects of estrogen on the vascular wall: vasomotor function and inflammation. Koh KK Cardiovasc Res; 2002 Sep; 55(4):714-26. PubMed ID: 12176121 [No Abstract] [Full Text] [Related]
16. Estrogens and the cardiovascular system: role of estradiol metabolites in hormone replacement therapy. Lippert TH; Seeger H; Mueck AO Climacteric; 1998 Dec; 1(4):296-301. PubMed ID: 11907937 [TBL] [Abstract][Full Text] [Related]